H2-blocker Therapy and Incidence of Necrotizing Enterocolitis in Preterm Infants: A Case-control Study
Authors:
- Petros GalanisPGPetros Galanis
- Christos BartsocasCBChristos Bartsocas
- Loukas SparosLSLoukas Sparos
- Emmanouil VelonakisEVEmmanouil Velonakis
- 1 April 2013
- journal article
- Published by Elsevier in Pediatrics & Neonatology
- Vol. 54 (2) , 141-142
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Ranitidine is Associated With Infections, Necrotizing Enterocolitis, and Fatal Outcome in NewbornsPediatrics, 2012
- Necrotizing enterocolitis: A multifactorial disease with no cureWorld Journal of Gastroenterology, 2008
- Necrotising enterocolitisThe Lancet, 2006
- Association of H2-Blocker Therapy and Higher Incidence of Necrotizing Enterocolitis in Very Low Birth Weight InfantsPediatrics, 2006
- Prevention of Neonatal Necrotizing EnterocolitisJournal of Pediatric Gastroenterology and Nutrition, 1990
- Neonatal Necrotizing EnterocolitisAnnals of Surgery, 1978